Zyla Life Sciences Overview
- Year Founded
-
1995
- Status
-
Acquired/Merged
- Employees
-
127
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$232M
Zyla Life Sciences General Information
Description
Provider of opioids and other pain care drugs designed for commercialization and development of abuse-resistant formulations. The company offers licensed and approved products indicated in adult patients for the short-term management of moderate to moderately severe pain for which alternative treatments are inadequate, enabling healthcare professionals to provide better opioid treatment to individuals.
Contact Information
Website
www.egalet.comCorporate Office
- 600 Lee Road
- Suite 100
- Wayne, PA 19087
- United States
Corporate Office
- 600 Lee Road
- Suite 100
- Wayne, PA 19087
- United States
Zyla Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 20-May-2020 | $232M | Completed | Generating Revenue | ||
| 8. Bankruptcy: Admin/Reorg | 30-Oct-2018 | Completed | Bankruptcy: Admin/Reorg | |||
| 7. Secondary Transaction - Open Market | 29-Mar-2018 | Completed | Generating Revenue | |||
| 6. Secondary Transaction - Open Market | 02-Jan-2018 | Completed | Generating Revenue | |||
| 5. Secondary Transaction - Open Market | 18-Apr-2016 | Completed | Generating Revenue | |||
| 4. IPO | 06-Feb-2014 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 12-Sep-2013 | Completed | Generating Revenue | |||
| 2. Debt - General | 07-May-2012 | $14.3M | $41.9M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 14-Mar-2006 | $27.6M | $27.6M | Completed | Generating Revenue |
Zyla Life Sciences Comparisons
Industry
Financing
Details
Zyla Life Sciences Competitors (73)
One of Zyla Life Sciences’s 73 competitors is Sentynl Therapeutics, a Formerly PE-Backed company based in Solana Beach, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sentynl Therapeutics | Formerly PE-Backed | Solana Beach, CA | ||||
| Neurelis | Venture Capital-Backed | San Diego, CA | ||||
| Frenelle Pharma | Venture Capital-Backed | Plymouth, MN | ||||
| Centrexion Therapeutics | Venture Capital-Backed | Boston, MA | ||||
| Xalud Therapeutics | Venture Capital-Backed | New York, NY |
Zyla Life Sciences Patents
Zyla Life Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2019121686-A1 | Oral delivery of active drug substances | Inactive | 18-Dec-2017 | ||
| AU-2013285988-A1 | Abuse deterrent pharmaceutical compositions for controlled release | Inactive | 06-Jul-2012 | ||
| CA-2877183-A1 | Abuse deterrent pharmaceutical compositions for controlled release | Inactive | 06-Jul-2012 | ||
| EP-2877161-A1 | Abuse deterrent pharmaceutical compositions for controlled release | Inactive | 06-Jul-2012 | ||
| US-20140010873-A1 | Abuse deterrent pharmaceutical compositions for controlled release | Active | 06-Jul-2012 | A61K9/2031 |
Zyla Life Sciences Signals
Zyla Life Sciences Former Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 4BIO Capital | Venture Capital | Minority | ||
| Atlas Venture | Venture Capital | Minority | ||
| Bio Fund Management | Venture Capital | Minority | ||
| CLS Capital Group | Corporation | Minority | ||
| DKA Capital | PE/Buyout | Minority |
Zyla Life Sciences Investments & Acquisitions (2)
Zyla Life Sciences’s most recent deal was a Corporate Asset Purchase with Iroko Pharmaceuticals (4 Non-Narcotic Pain Products). The deal was made on 04-Feb-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Iroko Pharmaceuticals (4 Non-Narcotic Pain Products) | 04-Feb-2019 | Corporate Asset Purchase | Buildings and Property | ||
| Sprix | 08-Jan-2015 | Merger/Acquisition | Pharmaceuticals |
Zyla Life Sciences FAQs
-
When was Zyla Life Sciences founded?
Zyla Life Sciences was founded in 1995.
-
Where is Zyla Life Sciences headquartered?
Zyla Life Sciences is headquartered in Wayne, PA.
-
What is the size of Zyla Life Sciences?
Zyla Life Sciences has 127 total employees.
-
What industry is Zyla Life Sciences in?
Zyla Life Sciences’s primary industry is Drug Delivery.
-
Is Zyla Life Sciences a private or public company?
Zyla Life Sciences is a Private company.
-
What is the current valuation of Zyla Life Sciences?
The current valuation of Zyla Life Sciences is .
-
What is Zyla Life Sciences’s current revenue?
The current revenue for Zyla Life Sciences is .
-
How much funding has Zyla Life Sciences raised over time?
Zyla Life Sciences has raised $109M.
-
Who are Zyla Life Sciences’s investors?
4BIO Capital, Atlas Venture, Bio Fund Management, CLS Capital Group, and DKA Capital are 5 of 14 investors who have invested in Zyla Life Sciences.
-
Who are Zyla Life Sciences’s competitors?
Sentynl Therapeutics, Neurelis, Frenelle Pharma, Centrexion Therapeutics, and Xalud Therapeutics are some of the 73 competitors of Zyla Life Sciences.
-
When was Zyla Life Sciences acquired?
Zyla Life Sciences was acquired on 20-May-2020.
-
Who acquired Zyla Life Sciences?
Zyla Life Sciences was acquired by Assertio Holdings.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process